KFA
RDY icon

Krane Funds Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Krane Funds Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,690
Closed -$86.6K – 223
2019
Q1 		$86.6K Sell
10,690
-10,955
-51% -$83.2K 0.01% 75
2018
Q4 		$411K Sell
21,645
-6,190
-22% -$43.5K 0.02% 66
2018
Q3 		$420K Buy
27,835
+4,320
+18% +$28.9K 0.03% 63
2018
Q2 		$329K Buy
23,515
+20,955
+819% +$132K 0.03% 63
2018
Q1 		$17K Buy
+2,560
New +$17.9K ﹤0.01% 77

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Krane Funds Advisors's RDY Position: Q2 2019 in Review

Krane Funds Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q2 2019, closing a stake of 10,690 shares — an estimated $86.6K sold.

Krane Funds Advisors first reported a position in RDY in Q1 2018 and held it in 5 quarters. The position peaked at $420K in Q3 2018. 150 funds tracked by Wall St. Rank hold RDY as of Q2 2019.

  • Krane Funds Advisors reported no remaining Dr. Reddy's Laboratories position as of Q2 2019 after selling out during the quarter.
  • Krane Funds Advisors sold 10,690 Dr. Reddy's Laboratories shares in Q2 2019, an estimated $86.6K.
  • Krane Funds Advisors first reported a position in Dr. Reddy's Laboratories in Q1 2018 and held it in 5 quarters.
  • Krane Funds Advisors's Dr. Reddy's Laboratories position peaked at $420K in Q3 2018.
  • 150 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2019.

Based on Krane Funds Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.